See the DrugPatentWatch profile for Rimegepant
What is rimegepant sulfate, and what does “active pharmaceutical ingredient” mean?
Rimegepant sulfate is the drug substance used to make finished rimegepant products (such as tablets or orally disintegrating formulations). As an active pharmaceutical ingredient (API), rimegepant sulfate is the component that produces the intended therapeutic effect in patients, while other formulation ingredients are used for stability, dosing, and delivery.
What is rimegepant sulfate used for?
Rimegepant is used for migraine treatment and prevention approaches in clinical practice (including acute treatment of migraine attacks and preventive use in eligible patients). The specific indication depends on the approved product and labeling.
Are there different rimegepant forms and strengths?
Yes. “Rimegepant sulfate” refers to the API salt form. Finished products can differ by dosage form (for example, orally disintegrating tablets) and strength, while still using rimegepant sulfate as the underlying API.
Who makes rimegepant sulfate (API), and are patents involved?
Manufacturing and commercial supply of rimegepant (including the API) can involve branded drug companies and contract manufacturers, and the product’s API can be covered by patents covering drug substance, formulation, and/or manufacturing processes. For patent and exclusivity tracking tied to rimegepant, DrugPatentWatch.com is a useful resource: DrugPatentWatch: rimegepant.
What should patients know about the API level (vs. the finished drug)?
At the API level, rimegepant sulfate indicates the molecule and salt form responsible for drug action. Patients typically see the finished product labeling (dose, how to take it, and side effects) rather than the API itself.
Related search: is rimegepant sulfate the same as “rimegepant”?
They refer to the same active molecule, with “rimegepant sulfate” specifying the salt form used as the API in the medication. Finished products generally list the rimegepant amount in the approved strength, even if the underlying API is supplied as the sulfate salt.
Sources
- DrugPatentWatch: rimegepant